Arjuna Capital Purchases 107 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Arjuna Capital grew its holdings in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 0.9% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 12,492 shares of the healthcare conglomerate’s stock after buying an additional 107 shares during the quarter. UnitedHealth Group makes up 2.3% of Arjuna Capital’s portfolio, making the stock its 10th largest position. Arjuna Capital’s holdings in UnitedHealth Group were worth $6,298,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in UNH. Axiom Financial Strategies LLC bought a new stake in UnitedHealth Group in the 1st quarter valued at $210,000. McGowan Group Asset Management Inc. lifted its position in shares of UnitedHealth Group by 8.9% during the 1st quarter. McGowan Group Asset Management Inc. now owns 744 shares of the healthcare conglomerate’s stock worth $379,000 after buying an additional 61 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its position in shares of UnitedHealth Group by 31.8% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 250,196 shares of the healthcare conglomerate’s stock worth $127,592,000 after buying an additional 60,300 shares during the last quarter. MAS Advisors LLC raised its position in UnitedHealth Group by 10.8% in the first quarter. MAS Advisors LLC now owns 463 shares of the healthcare conglomerate’s stock valued at $241,000 after purchasing an additional 45 shares during the last quarter. Finally, First Western Trust Bank bought a new position in UnitedHealth Group in the first quarter valued at about $875,000. Institutional investors own 85.69% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the company. HSBC restated a “reduce” rating and set a $480.00 price objective (down from $550.00) on shares of UnitedHealth Group in a research report on Monday, December 18th. Truist Financial restated a “buy” rating and set a $610.00 price objective on shares of UnitedHealth Group in a research report on Thursday, November 30th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $596.00 target price on shares of UnitedHealth Group in a research note on Tuesday, January 16th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a research note on Friday, January 19th. Finally, StockNews.com cut UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research note on Saturday, October 21st. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average target price of $575.79.

Read Our Latest Stock Analysis on UnitedHealth Group

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Stephen J. Hemsley sold 66,081 shares of the business’s stock in a transaction on Tuesday, December 5th. The stock was sold at an average price of $550.39, for a total value of $36,370,321.59. Following the sale, the director now directly owns 635,528 shares in the company, valued at $349,788,255.92. The sale was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 0.35% of the company’s stock.

UnitedHealth Group Stock Performance

UnitedHealth Group stock traded down $3.76 during mid-day trading on Monday, reaching $514.46. 353,763 shares of the company’s stock were exchanged, compared to its average volume of 4,202,995. The business’s fifty day simple moving average is $525.36 and its 200 day simple moving average is $517.84. The firm has a market capitalization of $475.83 billion, a PE ratio of 21.74, a P/E/G ratio of 1.41 and a beta of 0.54. UnitedHealth Group Incorporated has a one year low of $445.68 and a one year high of $554.70. The company has a quick ratio of 0.80, a current ratio of 0.79 and a debt-to-equity ratio of 0.62.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 EPS for the quarter, topping analysts’ consensus estimates of $5.98 by $0.18. The business had revenue of $94.43 billion for the quarter, compared to analyst estimates of $92.13 billion. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. UnitedHealth Group’s quarterly revenue was up 14.1% compared to the same quarter last year. During the same period last year, the company posted $5.34 earnings per share. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 27.84 earnings per share for the current year.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

See Also

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.